These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 14963012

  • 1. Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells.
    Lee HH, Ho CT, Lin JK.
    Carcinogenesis; 2004 Jul; 25(7):1109-18. PubMed ID: 14963012
    [Abstract] [Full Text] [Related]

  • 2. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C, Varela C, Correia-da-Silva G, Tavares da Silva E, Carvalho RA, Costa SC, Cunha SC, Fernandes JO, Teixeira N, Roleira FM.
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [Abstract] [Full Text] [Related]

  • 3. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q, Titus MA, Fung KM, Lin HK.
    J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 15; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 6. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
    Nunlist EH, Dozmorov I, Tang Y, Cowan R, Centola M, Lin HK.
    J Steroid Biochem Mol Biol; 2004 Jul 15; 91(3):157-70. PubMed ID: 15276623
    [Abstract] [Full Text] [Related]

  • 7. 5alpha-reductase isozymes and androgen actions in the prostate.
    Zhu YS, Imperato-McGinley JL.
    Ann N Y Acad Sci; 2009 Feb 15; 1155():43-56. PubMed ID: 19250191
    [Abstract] [Full Text] [Related]

  • 8. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
    Kuo PT, Lin TP, Liu LC, Huang CH, Lin JK, Kao JY, Way TD.
    J Agric Food Chem; 2009 Apr 22; 57(8):3331-9. PubMed ID: 19320436
    [Abstract] [Full Text] [Related]

  • 9. Anti-androgenic activity of fatty acids.
    Liu J, Shimizu K, Kondo R.
    Chem Biodivers; 2009 Apr 22; 6(4):503-12. PubMed ID: 19353546
    [Abstract] [Full Text] [Related]

  • 10. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
    Schatzl G, Madersbacher S, Gsur A, Preyer M, Haidinger G, Haitel A, Vutuc C, Micksche M, Marberger M.
    Prostate; 2002 Jul 01; 52(2):130-8. PubMed ID: 12111704
    [Abstract] [Full Text] [Related]

  • 11. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM, Frazier MC, Harris WB.
    Anticancer Res; 2007 Jul 01; 27(3B):1483-8. PubMed ID: 17595765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.
    Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW, Knudsen KE.
    Cancer Res; 2005 Jan 01; 65(1):54-65. PubMed ID: 15665279
    [Abstract] [Full Text] [Related]

  • 14. Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate.
    Corradi LS, Góes RM, Vilamaior PS, Taboga SR.
    Microsc Res Tech; 2009 Dec 01; 72(12):939-50. PubMed ID: 19484778
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 16. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B, Mayer D.
    Int J Oncol; 2008 Sep 01; 33(3):623-9. PubMed ID: 18695894
    [Abstract] [Full Text] [Related]

  • 17. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
    Maria McCrohan A, Morrissey C, O'Keane C, Mulligan N, Watson C, Smith J, Fitzpatrick JM, Watson RW.
    Cancer; 2006 Jun 15; 106(12):2743-52. PubMed ID: 16703599
    [Abstract] [Full Text] [Related]

  • 18. Sex steroid hormone metabolism and prostate cancer.
    Soronen P, Laiti M, Törn S, Härkönen P, Patrikainen L, Li Y, Pulkka A, Kurkela R, Herrala A, Kaija H, Isomaa V, Vihko P.
    J Steroid Biochem Mol Biol; 2004 Nov 15; 92(4):281-6. PubMed ID: 15663991
    [Abstract] [Full Text] [Related]

  • 19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 20. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
    Attardi BJ, Burgenson J, Hild SA, Reel JR.
    Mol Cell Endocrinol; 2004 Jul 30; 222(1-2):121-32. PubMed ID: 15249132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.